Biotech News - Medipacs Develops New Photo Activated Polymer Actuator

Medipacs Develops New Photo Activated Polymer Actuator

Medipacs, a Tucson AZ. biotech company, has announced the
development of a new photo (light) activated polymer actuator that
can reversibly expand and contract up to 100% in volume.

Tucson, AZ - Medipacs, a Tucson AZ. biotech company, has announced
the development of a new photo (light) activated polymer actuator
that can reversibly expand and contract up to 100% in volume and
produce pressures greater than 2 pounds per square inch when exposed
to certain wavelengths of light. The new patent pending material has
been in development for two years and is intended for use in the
Pulse Activated Cell System or PACS. The proprietary PACS Digital
Pump™ technology is being developed by Medipacs to drive or pump
fluids for drug delivery and infusion therapies in the medical
market.

The new photo activated polymer is a major breakthrough in an effort
to develop an extremely low energy consuming pump system. This
polymer will enable systems and systems components that use very
little or no electrical power at all. and it is viewed as a major
building block of the Medipacs system and components. Company
spokesperson Laurie Hassey envisions its use beyond medical devices
and as a new alternative energy technology. "Once you realize that
by simply exposing the material to light generates movement of the
material you start to see the possibilities. We envision uses from
water pumps for remote areas and third world countries to active
materials that can bend or track in the direction of the sun, in
much the same way a living plant does. These and other concepts take
advantage of a photo chemical process in the polymer and do not need
any electrical power to create movement."

Medipacs is a startup company at the Arizona Center for Innovation a
business incubator located at the University of Arizona Science and
Technology Park. The company is developing the next generation of
medical pump and drug delivery devices that interact with the
patient, autonomously monitoring, mixing and delivering drugs and
fluids according to the patients needs. Future devices are in the
form of pre-dosed patches, ambulatory monitors with interactive
pumps, artificial organs and bioreactors.

The Medipacs device is not FDA approved and is in research and
development stages.

This news release may contain forward looking information. Actual
future results may differ materially from those contemplated. The
risks, uncertainties and other factors, both known & unknown, could
influence actual results may be substantial & include those
described in documents filed with regulatory authorities. No
assurances can be given that any of the events anticipated by the
forward looking statements will transpire or occur, or if any of
them do so, what benefits the company will derive there from.

http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/

<*> Your email settings:
Individual Email | Traditional

<*> To change settings online go to:
http://groups.yahoo.com/group/biotech-news/join
(Yahoo! ID required)

<*> To change settings via email:
mailto:biotech-news-digest@yahoogroups.com
mailto:biotech-news-fullfeatured@yahoogroups.com

<*> To unsubscribe from this group, send an email to:
biotech-news-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/